History Taking for Tingling and Numbness
When evaluating tingling and numbness, systematically determine the sensory distribution, identify any associated weakness, establish the temporal pattern (acute vs. chronic, episodic vs. constant), and identify potential causative factors including medication exposures, metabolic conditions, and trauma.
Essential Components to Elicit
1. Symptom Characterization
- Sensory quality: Distinguish between numbness, tingling (paresthesias), and pain—numbness and tingling typically appear earlier than pain in peripheral neuropathies 1
- Distribution pattern:
- Stocking-glove distribution suggests length-dependent peripheral neuropathy, beginning distally in fingers and toes and progressing proximally 1
- Specific finger involvement (thumb/index/middle = median nerve; little finger/ulnar ring finger = ulnar nerve) suggests focal nerve entrapment 2
- Upper vs. lower extremity predominance can differentiate etiologies
2. Temporal Pattern
- Onset: Acute (hours to days) vs. subacute (weeks) vs. chronic (months to years)
- Progression: Static, worsening, improving, or fluctuating
- Duration: Constant vs. episodic attacks
- Time course specifics:
3. Associated Motor Symptoms
- Weakness: If present, identify specific muscle groups affected to localize pathology (nerve root, plexus, or peripheral nerve) 3
- Functional impairment: Difficulty with fine motor tasks, grip strength, walking, balance
4. Medication and Exposure History
- Neurotoxic chemotherapy: Specifically ask about paclitaxel, oxaliplatin, platinum agents, vinca alkaloids, and taxanes 1
- Other medications: Inquire about any new medications or dose changes
- Toxin exposures: Alcohol consumption, occupational exposures
5. Risk Factors and Comorbidities
- Metabolic conditions: Diabetes mellitus, hypothyroidism 2
- Inflammatory conditions: Rheumatoid arthritis 2
- Lifestyle factors: Smoking, alcohol use 2
- Cancer history: Current or past malignancy and treatments received 1
6. Anatomic Localization Questions
- Unilateral vs. bilateral: Bilateral symptoms suggest systemic etiology; unilateral suggests focal nerve pathology 2
- Proximal vs. distal: Helps differentiate radiculopathy from peripheral neuropathy
- Upper extremity specific:
7. Impact on Quality of Life
- Functional limitations: Activities of daily living affected, work capacity, sleep disturbance
- Pain severity: If painful neuropathy present, quantify intensity and character 1
- Safety concerns: Falls, difficulty with ambulation, inability to detect injury
Critical Pitfalls to Avoid
- Don't assume a single etiology: Multiple neuropathic conditions can co-occur in the same patient, requiring separate assessment of each 4
- Don't overlook "other good reasons": The diagnosis of chemotherapy-induced neuropathy requires excluding alternative explanations for symptoms 1
- Don't miss bilateral presentations of focal entrapments: While carpal tunnel and cubital tunnel syndromes can be bilateral, this typically occurs in the context of systemic risk factors like diabetes or rheumatoid arthritis 2
When Electrodiagnostic Testing is Needed
Clinical history alone can establish the diagnosis in most cases of chemotherapy-induced peripheral neuropathy 1. However, EMG and nerve conduction studies should be considered when:
- The diagnosis remains unclear after history and examination
- Confirmation and specific localization are needed for surgical planning 3
- Differentiating between cervical radiculopathy, thoracic outlet syndrome, and peripheral nerve entrapment 2
Note that nerve conduction studies in asymptomatic patients receiving neurotoxic chemotherapy can predict neuropathy development but are not routinely recommended 1.